Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Original Research
Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,111 | Dovepress* | 3,867+ | 489 | 4,356 | |
| PubMed Central* | 244 | 88 | 332 | ||
| Totals | 4,111 | 577 | 4,688 | ||
| *Since 8 June 2021 | |||||
View citations on PubMed Central and Google Scholar